EE281 Cost-Effectiveness Analysis of Bimekizumab in Patients with Axial Spondyloarthritis (AXSPA) in Greece

M Koulentaki, S Ravanidis, D Daoussis, T Dimitroulas,C Papagoras, P Sfikakis,V Kountouris, M Feretos,G Kourlaba, N Lyris,D Willems

Value in Health（2024）

Cited 0|Views2

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined